SMTL ID : 8txy.2 (1 other biounit)

X-ray crystal structure of JRD-SIK1/2i-3 bound to a MARK2-SIK2 chimera

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)

PEG.1: 1 residues within 4Å: Chain A: E.76 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:E.76

1 x SJ0: N-[(5P,8R)-5-(2-cyano-5-{[(3R)-1-methylpyrrolidin-3-yl]methoxy}pyridin-4-yl)pyrazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide

SJ0.2: 18 residues within 4Å: Chain A: L.13, K.36, M.58, I.67, L.81, T.83, E.84, Y.85, A.86, K.87, N.88, G.89, E.90, E.133, N.134, L.136, A.146, D.147 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:I.67 Hydrogen bonds: A:K.36, A:A.86, A:A.86 Salt bridges: A:E.90, A:D.147

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Babbe, H. et al., Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation. Proc.Natl.Acad.Sci.USA (2024)

Release Date

2024-01-10

Peptides

Serine/threonine-protein kinase MARK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Serine/threonine-protein kinase MARK2

Related Entries With Identical Sequence